Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Oral Health

No studies found 0 · 0%GRADE not reported 4 · 100%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Wits appraisal · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)

Facemask with rapid maxillary expansion (RME) showed no clear difference in wits appraisal compared with pushing Splints; GRADE not reported.

1 finding from 1 review

Orthodontic treatment for prominent lower front teeth (Class III malocclusion) in children 2024 · Cochrane All outcomes
End of treatment
MD 0.70 [-0.60, 2.00]
1 study · 42 participants
GRADE not reported

Adverse effects · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)

1 finding from 1 review

Orthodontic treatment for prominent lower front teeth (Class III malocclusion) in children 2024 · Cochrane All outcomes
End of treatment
Galeotti 2021: occasional skin irritation on the chin and three appliance breakages (one facemask, two Pushing Splints).
1 study · 42 participants
GRADE not reported

Overjet · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)

Facemask with rapid maxillary expansion (RME) showed no clear difference in overjet compared with pushing Splints; GRADE not reported.

1 finding from 1 review

Orthodontic treatment for prominent lower front teeth (Class III malocclusion) in children 2024 · Cochrane All outcomes
End of treatment
MD 0.80 [-0.37, 1.97]
1 study · 42 participants
GRADE not reported

ANB (ANPog) · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion)

Facemask with rapid maxillary expansion (RME) led to higher ANB (ANPog) compared with pushing Splints; GRADE not reported.

1 finding from 1 review

Orthodontic treatment for prominent lower front teeth (Class III malocclusion) in children 2024 · Cochrane All outcomes
End of treatment
MD 1.40 [0.29, 2.51]
1 study · 42 participants
GRADE not reported